Cementos Bio-B (CEMENTOS) — Capital Reinvestment Ratio
Cementos Bio-B (CEMENTOS) has a Capital Reinvestment Ratio of 0.27x as of March 2023, meaning it reinvests 0% of its operating cash flow (CL$11.65 Billion) in capital expenditures (CL$3.19 Billion). See CEMENTOS net asset quality score to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Cementos Bio-B Capital Reinvestment Ratio (2014–2021)
This chart tracks Cementos Bio-B's Capital Reinvestment Ratio across 8 annual periods. Check how aggressively does Cementos Bio-B reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Cementos Bio-B (2014–2021)
Year-by-year Capital Reinvestment Ratio for Cementos Bio-B from 2014 to 2021. For live market cap and broader valuation context, see CEMENTOS company net worth.
| Year | Reinvestment Ratio | Operating CF (CLP) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.85x | CL$25.84 Billion | CL$21.98 Billion | ▲ +205.7% |
| 2020 | 0.28x | CL$33.56 Billion | CL$9.34 Billion | ▼ -32.4% |
| 2019 | 0.41x | CL$30.23 Billion | CL$12.45 Billion | ▼ -3.0% |
| 2018 | 0.42x | CL$38.26 Billion | CL$16.24 Billion | ▲ +8.3% |
| 2017 | 0.39x | CL$21.74 Billion | CL$8.52 Billion | ▲ +311.1% |
| 2016 | 0.10x | CL$55.95 Billion | CL$5.33 Billion | ▼ -8.7% |
| 2015 | 0.10x | CL$49.64 Billion | CL$5.18 Billion | ▼ -42.3% |
| 2014 | 0.18x | CL$41.47 Billion | CL$7.51 Billion | — |